Optiemus Infracom Fund Raise of ₹216.9 Cr

Optiemus Infracom Other Announcement

Optiemus Infracom filed the final ICRA monitoring report on its preferential issue, showing no material deviation. All issue proceeds were fully utilised by September 30, 2026.

Optiemus Infracom Investor Presentation: Key Takeaways

Q2 FY27 record revenue ₹983 cr (+135% YoY), EBITDA ₹40 cr (4.08% margin), PAT ₹21 cr (+25% YoY). Strategy pivots to screen protectors, CMF JV, cover glass and FY29 ₹8,500 cr target.

Call

Guides 100% growth

Optiemus Infracom Fund Raise

Optiemus Infracom's board approved a fund raise, with mode and amount yet undecided. Details will follow after finalisation.

Optiemus Infracom Q2 FY27 Results: Net Profit ₹21 Cr, Up 25.0% YoY

Optiemus Infracom Ltd reported revenue from operations of ₹983.2 Cr (+135.0% YoY) and net profit of ₹21 Cr (+25.0% YoY) for Q2 FY27.

Key figure

Net profit ₹21 Cr · +25.0% YoY

Optiemus Infracom Board Meeting Date

Optiemus Infracom notified a board meeting on 05 Nov 2026 to consider a fund raise and unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes 01 Oct to 07 Nov 2026.

Optiemus Infracom Debt & Borrowing: ₹50 Cr

Optiemus approved a Rs 50 Crore unsecured loan to subsidiary GDN Enterprises at 8.50% for three years. The agreement was executed 27 October 2026 for working capital.

Value

₹50.00 Cr

Execution

3 years

Flywings Simulator Training Centre Fund Raise of ₹73.2 Cr

Flywings approved preferential issue of up to 29,87,760 warrants at Rs 245, aggregating Rs 73.20 crore. Shareholder approval is sought at an EGM on November 27, 2026.

Value

₹73.20 Cr

Upsurge Investment & Finance Fund Raise of ₹20 Cr

Upsurge Investment & Finance approved unaudited Q2 FY27 results, appointed Manish Kabra as CFO, and approved raising up to Rs.20 Crore. The raise needs shareholder and regulatory approvals before proceeding.

Value

₹20.00 Cr

Jonjua Overseas Fund Raise of ₹14.7 Cr

Jonjua Overseas board approved raising up to Rs 14.70 crore more capital via a fund-raising committee. Board also noted a changed CIN and a paid BSE fine.

Value

₹14.70 Cr

AGI Infra Fund Raise

AGI Infra shareholders approved a special resolution to raise funds via QIP through postal ballot. Votes in favour were 100% of votes polled; no amount stated.

Pajson Agro India Fund Raise of ₹354.5 Cr

Pajson Agro's board approved a Rs.354.52 Crore preferential issue of 1,20,58,397 equity shares at Rs.294 each. Shareholder approval is sought at a meeting on 04-12-2026.

Value

₹354.5 Cr

Evonile Pharma Fund Raise of ₹900 Cr

Evonile Pharma's board approved a partly paid rights issue of up to Rs 900 Crore. A committee will set the issue price, record date and entitlement.

Value

₹900.0 Cr